MPTP treatment significantly reduced the protein levels of SOD1 (p < 0.01), SOD2 (p < 0.0001), Nrf2 and HO-1 (both p < 0.01), indicating pronounced oxidative damage in PD mice. Here, SOD1 is linked to Parkinson disease.